移植后的IgA脏病
1Department of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA.
Seminars in nephrology
|March 14, 2025
概括
免疫球蛋白A (IgA) 病症在移植后经常复发,影响移植的存活率. 研究正在探索生物标志物和自身免疫机制,以更好地管理移植后的IgA脏病.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 免疫球蛋白A (IgA) 病是全球衰竭的主要原因之一.
- 移植是因IgA脏病变导致的末期病的主要治疗方法.
- 移植后IgA脏病的复发是常见的,并减少了移植的寿命.
研究的目的:
- 审查移植后IgA脏病的危险因素,临床表现和管理策略.
- 突出在移植的背景下对生物标志物验证的需要.
- 探索针对复发性IgA脏病的新型自身免疫向疗法的潜力.
主要方法:
- 对移植后IgA病复发研究的文献综述.
- 分析与复发相关的接受者和供体因素.
- 检查免疫抑制在改变疾病表现中的作用.
- 审查当前和新兴的治疗策略.
主要成果:
- 接受者和捐赠者的特征影响IgA脏病复发风险,尽管研究结果在不同研究中有所不同.
- 免疫抑制疗法可以改变移植后IgA脏病的临床表现.
- 在原生IgA脏病中发现的生物标志物需要在移植环境中进行验证.
- 目前针对复发性IgA脏病的治疗主要依赖于支持性护理和来自本源脏病的证据.
结论:
- 了解IgA脏病中的自身免疫机制为移植后复发提供了潜在的治疗点.
- 需要进一步的研究来验证生物标志物并完善移植受体中复发性IgA病的治疗方案.
- 优化免疫抑制和探索新疗法对于改善IgA脏病患者的全移植存活率至关重要.
相关概念视频
Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...


